{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T15:40:14Z","timestamp":1758987614997,"version":"3.44.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2001,7,1]],"date-time":"2001-07-01T00:00:00Z","timestamp":993945600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2001,7,1]],"date-time":"2001-07-01T00:00:00Z","timestamp":993945600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection"],"published-print":{"date-parts":[[2001,7]]},"DOI":"10.1053\/jinf.2001.0837","type":"journal-article","created":{"date-parts":[[2002,9,19]],"date-time":"2002-09-19T09:56:27Z","timestamp":1032429387000},"page":"235-242","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Contribution of Alveolar Phagocytes to Antibiotic Efficacy in an Experimental Lung Infection with Streptococcus pneumoniae"],"prefix":"10.1016","volume":"42","author":[{"given":"W.","family":"Calame","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.E.","family":"Douwes-Idema","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.Th.van den","family":"Barselaar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Mattie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/jinf.2001.0837_RF1","first-page":"315","article-title":"Physiology and pathophysiology of pulmonary macrophages","volume":"vol. 7b","author":"Brain","year":"1985"},{"key":"10.1053\/jinf.2001.0837_RF2","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1172\/JCI107788","article-title":"Pulmonary alveolar macrophage: defender against bacterial infection of the lung","volume":"54","author":"Goldstein","year":"1977","journal-title":"J Clin Invest"},{"key":"10.1053\/jinf.2001.0837_RF3","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1093\/infdis\/133.3.310","article-title":"Murine pulmonary alveolar macrophages: rates of bacterial ingestion, inactivation and destruction","volume":"133","author":"Kim","year":"1976","journal-title":"J Infect Dis"},{"key":"10.1053\/jinf.2001.0837_RF4","first-page":"335","article-title":"Granulocyte\u2013alveolar\u2013macrophage interaction in the pulmonary clearance of Staphylococcus aureus","volume":"127","author":"Onofrio","year":"1983","journal-title":"Am Rev Respir Dis"},{"key":"10.1053\/jinf.2001.0837_RF5","first-page":"222","article-title":"Pulmonary clearance and phagocytic cell response to normal pharyngeal flora","volume":"123","author":"Onofrio","year":"1981","journal-title":"Am Rev Respir Dis"},{"key":"10.1053\/jinf.2001.0837_RF6","first-page":"559","article-title":"The relationship of inoculum size to lung bacterial clearance and phagocytic cell response in mice","volume":"120","author":"Toews","year":"1979","journal-title":"Am Rev Respir Dis"},{"key":"10.1053\/jinf.2001.0837_RF7","first-page":"280","article-title":"Phagocytic cells: development biology of neutrophils and eosinophils","author":"Ford Bainton","year":"1988"},{"key":"10.1053\/jinf.2001.0837_RF8","unstructured":"Van Furth, R, Development and distribution of mononuclear phagocytes in normal steady state and inflammation, Gallin, JIGoldstein, IMSnyderman, R, Inflammation: Basic Principles and Clinical Correlates, New York, Raven Press Ltd, 1988, 281, 295"},{"key":"10.1053\/jinf.2001.0837_RF9","unstructured":"Gourley, MF, Seldin, MF, Steinberg, AD, Immunoregulatory Agents, Gallin, JIGoldstein, IMSnyderman, R, Inflammation: Basic Principles and Clinical Correlates, Second Edition, New York, Raven Press Ltd, 1992, 1103, 1126"},{"key":"10.1053\/jinf.2001.0837_RF10","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1128\/AAC.33.6.980","article-title":"Influence of etoposide and cyclophosphamide on the efficacy of cloxacillin and erythromycin in an experimental staphylococcal infection","volume":"33","author":"Calame","year":"1989","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1053\/jinf.2001.0837_RF11","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0163-4453(94)95087-3","article-title":"Influence of cytostatic agents on the pulmonary defense of mice infected with Klebsiella pneumoniae and on the efficacy of treatment with ceftriaxone","volume":"29","author":"Calame","year":"1994","journal-title":"J Infection"},{"key":"10.1053\/jinf.2001.0837_RF12","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1093\/infdis\/137.6.764","article-title":"Pathogenesis of Pseudomonas aeruginosa pneumonia during immunosuppression","volume":"137","author":"Pennington","year":"1987","journal-title":"J Infect Dis"},{"key":"10.1053\/jinf.2001.0837_RF13","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1172\/JCI109844","article-title":"Early bacterial clearance from murine lungs. Species-dependent phagocyte response","volume":"66","author":"Rehm","year":"1980","journal-title":"J Clin Invest"},{"key":"10.1053\/jinf.2001.0837_RF14","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1183\/09031936.93.01050415","article-title":"The epidemiology of respiratory tract pathogens in Southern Netherlands","volume":"1","author":"Davies","year":"1988","journal-title":"Eur Respir J"},{"key":"10.1053\/jinf.2001.0837_RF15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0002-9343(83)91110-5","article-title":"Changing spectrum of pneumonia \u2013 News media creation or clinical reality?","volume":"74","author":"Fick","year":"1983","journal-title":"Am J Med"},{"key":"10.1053\/jinf.2001.0837_RF16","first-page":"471","article-title":"Bacterial pneumonias","author":"LaForce","year":"1992"},{"key":"10.1053\/jinf.2001.0837_RF17","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1378\/chest.95.1.130","article-title":"Pulmonary infiltrates in immunocompromised patients","volume":"59","author":"Xaubet","year":"1989","journal-title":"Chest"},{"key":"10.1053\/jinf.2001.0837_RF18","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/BF02014330","article-title":"Efficacy of continous versus intermittent administration of penicillin G in Streptococcus pneumoniae pneumonia in normal and immunodeficient rats","volume":"3","author":"Bakker-Woudenburg","year":"1984","journal-title":"Eur J Clin Microb"},{"key":"10.1053\/jinf.2001.0837_RF19","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/0022-1759(85)90486-7","article-title":"Method to select mice in the steady state for biological studies","volume":"760","author":"Sluiter","year":"1985","journal-title":"J Immunol Methods"},{"key":"10.1053\/jinf.2001.0837_RF20","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1084\/jem.149.6.1504","article-title":"Origin, kinetics and characteristics of pulmonary macrophages in the normal steady state","volume":"149","author":"Bluss\u00e9 van Oud Alblas","year":"1982","journal-title":"J Exp Med"},{"year":"1971","series-title":"Statistical methods in medical research","author":"Armitage","key":"10.1053\/jinf.2001.0837_RF21"},{"key":"10.1053\/jinf.2001.0837_RF22","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/BF02126564","article-title":"Effect of etoposide and cyclophosphamide on an experimental pulmonary infection in mice","volume":"26","author":"Calame","year":"1989","journal-title":"Agents Actions"},{"key":"10.1053\/jinf.2001.0837_RF23","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1007\/PL00000205","article-title":"Neuroendocrine and immune interactions with airway macrophages","volume":"49","author":"James","year":"2000","journal-title":"Inflamm Res"},{"key":"10.1053\/jinf.2001.0837_RF24","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1007\/BF01645301","article-title":"Antibacterial defence mechanism","volume":"11","author":"Hahn","year":"1983","journal-title":"Infection"},{"key":"10.1053\/jinf.2001.0837_RF25","unstructured":"Rosenstreich, Dl, The macrophage, Oppenheim, JJRosenstreich, DLPotter, M, Cellular functions in immunity and inflammation, New York, Elsevier, 1981, 127, 159"},{"key":"10.1053\/jinf.2001.0837_RF26","doi-asserted-by":"crossref","first-page":"3972","DOI":"10.4049\/jimmunol.135.6.3972","article-title":"Cachectin\/tumor necrosis factor: Production, distribution and metabolic fate in vivo","volume":"135","author":"Beutler","year":"1985","journal-title":"J Immunol"},{"key":"10.1053\/jinf.2001.0837_RF27","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1165\/ajrcmb\/1.1.57","article-title":"Differential regulation of tumor necrosis factor-alpha in human alveolar macrophages and peripheral blood monocytes: a cellular and molecular analysis","volume":"1","author":"Strieter","year":"1989","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1053\/jinf.2001.0837_RF28","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1002\/jlb.43.5.429","article-title":"Protective effects of tumor necrosis factor in experimental Legionella pneumophila infections of mice via activation of PMN function","volume":"43","author":"Blanchard","year":"1988","journal-title":"J Leukocyte Biol"},{"key":"10.1053\/jinf.2001.0837_RF29","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/0006-291X(87)90432-3","article-title":"Purification and amino acid sequencing of NAF, a novel neutrophil activating factor produced by monocytes","volume":"149","author":"Walz","year":"1987","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1053\/jinf.2001.0837_RF30","doi-asserted-by":"crossref","first-page":"9233","DOI":"10.1073\/pnas.84.24.9233","article-title":"Purification of a human monocyte-derived neutrophil chemotactic factor that shares sequence homology with other host defense cytokines","volume":"84","author":"Yoshimura","year":"1987","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1053\/jinf.2001.0837_RF31","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1006\/clin.1996.0130","article-title":"Regulation of human alveolar macrophage inflammatory cytokine production by interleukin-10","volume":"80","author":"Thomassen","year":"1996","journal-title":"Clin Immunol Immunop"},{"key":"10.1053\/jinf.2001.0837_RF32","first-page":"19","article-title":"Effects of antimicrobial drugs on humanneutrophil\u2013microbe interactions","volume":"57","author":"Pallister","year":"2000","journal-title":"Br J Biomed"},{"key":"10.1053\/jinf.2001.0837_RF33","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1165\/ajrcmb.15.6.8969274","article-title":"Asbestos induction of nuclear transcription factors and interleukin 8 gene regulation","volume":"15","author":"Simeonova","year":"1996","journal-title":"Am J Resp Cell Mol"},{"key":"10.1053\/jinf.2001.0837_RF34","first-page":"129A","article-title":"Lipid ozonation products (LOP) activate nuclear factors NF-IL6 and NF-x beta and release interleukin-8 (IL8) in human bronchial epithelial cells (BEAS-2B)","volume":"48","author":"Kafoury","year":"2000","journal-title":"J Invest Med"},{"key":"10.1053\/jinf.2001.0837_RF35","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1080\/019021499270277","article-title":"Respiratory epithelial cells release interleukin-8 in response to a thermophilic bacteria that causes hypersensitivity pneumonitis","volume":"25","author":"Gudmundsson","year":"1999","journal-title":"Exp Lung Res"}],"container-title":["Journal of Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445301908370?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445301908370?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T15:22:23Z","timestamp":1758986543000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163445301908370"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,7]]},"references-count":35,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2001,7]]}},"alternative-id":["S0163445301908370"],"URL":"https:\/\/doi.org\/10.1053\/jinf.2001.0837","relation":{},"ISSN":["0163-4453"],"issn-type":[{"type":"print","value":"0163-4453"}],"subject":[],"published":{"date-parts":[[2001,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Contribution of Alveolar Phagocytes to Antibiotic Efficacy in an Experimental Lung Infection with Streptococcus pneumoniae","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/jinf.2001.0837","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2001 The British Infection Society. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}